Table 1. Comparison Between Leishmania Lesion Sizes After Eight Weeks of Treatmenta,b.
Treatment, w | Group 1 | Group 2 | P Valuec | Group 3 | Group 4 | P Valuec |
---|---|---|---|---|---|---|
One | 1.53 ± 0.75 | 1.59 ± 0.62 | 0.953 | 1.76 ± 1.12 | 1.74 ± 0.93 | 0.758 |
Two | 2.63 ± 1.25 | 2.25 ± 1.61 | 0.356 | 3.61 ± 0.85 | 2.52 ± 0.76 | 0.276 |
Three | 3.68 ± 0.56 | 2.61 ± 1.56 | 0.391 | 6.92 ± 2.55 | 4.39 ± 1.57 | 0.096 |
Four | 5.96 ± 0.34 | 3.11 ± 0.98 | 0.088 | 7.43 ± 3.86 | 5.33 ± 1.66 | 0.072 |
Five | 6.88 ± 2.28 | 3.83 ± 1.55 | 0.031 | 9.11 ± 2.11 | 6.21 ± 2.54 | 0.033 |
Six | 7.91 ± 3.56 | 4.32 ± 1.27 | 0.046 | 9.93 ± 4.38 | 6.85 ± 3.14 | 0.024 |
Seven | 8.62 ± 3.25 | 4.58 ± 1.86 | 0.002 | 10.2 ± 5.84 | 7.12 ± 3.57 | 0.013 |
Eight | 8.95 ± 5.71 | 4.81 ± 3.22 | 0.0001 | 10.8 ± 6.32 | 7.81 ± 4.22 | 0.003 |
aGroup 1, placebo after inoculation; group 2, morphine ointment after inoculation; group 3, placebo after lesions present; group 4, morphine after lesions present.
bP value < 0.05 is considered significant.
cUsing independent Student’s t-test.